Targeting Duchenne muscular dystrophy by skipping DMD exon 45 with base editors

Targeting Duchenne muscular dystrophy by skipping DMD exon 45 with base editors

Duchenne muscular dystrophy is an X-linked monogenic disease caused by mutations in the dystrophin gene (DMD) characterized by progressive muscle weakness, leading to loss of ambulation and decreased life expectancy. Since the current standard of care for Duchenne muscular dystrophy is to merely tre...

Full description

Bibliographic Details
Main Authors:	Michael Gapinske, Jackson Winter, Devyani Swami, Lauren Gapinske, Wendy S. Woods, Shraddha Shirguppe, Angelo Miskalis, Anna Busza, Dana Joulani, Collin J. Kao, Kurt Kostan, Anne Bigot, Rashid Bashir, Pablo Perez-Pinera
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Series:	Molecular Therapy: Nucleic Acids
Subjects:	MT: RNA/DNA editing gene editing CRISPR-Cas9 Duchenne muscular dystrophy exon skipping adenine base editing
Online Access:	http://www.sciencedirect.com/science/article/pii/S2162253123002020

Similar Items

Prevention of early-onset cardiomyopathy in Dmd exon 52–54 deletion mice by CRISPR-Cas9-mediated exon skipping
by: Matthew Rok, et al.
Published: (2023-09-01)

CRISPR-SKIP: programmable gene splicing with single base editors
by: Michael Gapinske, et al.
Published: (2018-08-01)

Prime editing strategies to mediate exon skipping in DMD gene
by: Cedric Happi Mbakam, et al.
Published: (2023-05-01)

CRISPR Therapeutics for Duchenne Muscular Dystrophy
by: Esra Erkut, et al.
Published: (2022-02-01)

Single-swap editing for the correction of common Duchenne muscular dystrophy mutations
by: Andreas C. Chai, et al.
Published: (2023-06-01)

Correction of DMD in human iPSC-derived cardiomyocytes by base-editing-induced exon skipping
by: Peipei Wang, et al.
Published: (2023-03-01)

Repurposing Dantrolene for Long-Term Combination Therapy to Potentiate Antisense-Mediated DMD Exon Skipping in the mdx Mouse
by: Derek W. Wang, et al.
Published: (2018-06-01)

Networking to Optimize <i>Dmd</i> exon 53 Skipping in the Brain of <i>mdx52</i> Mouse Model
by: Mathilde Doisy, et al.
Published: (2023-12-01)

DMD antisense oligonucleotide mediated exon skipping efficiency correlates with flanking intron retention time and target position within the exon
by: Remko Goossens, et al.
Published: (2023-12-01)

Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne Muscular Dystrophy
by: Francesco Galli, et al.
Published: (2024-03-01)

Novel Cationic Carotenoid Lipids as Delivery Vectors of Antisense Oligonucleotides for Exon Skipping in Duchenne Muscular Dystrophy
by: Vassilia Partali, et al.
Published: (2012-01-01)

Multiple Exon Skipping in the Duchenne Muscular Dystrophy Hot Spots: Prospects and Challenges
by: Yusuke Echigoya, et al.
Published: (2018-12-01)

Genes adapt to outsmart gene-targeting strategies in mutant mouse strains by skipping exons to reinitiate transcription and translation
by: Vishnu Hosur, et al.
Published: (2020-07-01)

Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene
by: Kane L Greer, et al.
Published: (2014-01-01)

CRISPR/Cas9-mediated genome editing induces exon skipping by complete or stochastic altering splicing in the migratory locust
by: Dafeng Chen, et al.
Published: (2018-09-01)

RNA-Seq Analysis of an Antisense Sequence Optimized for Exon Skipping in Duchenne Patients Reveals No Off-Target Effect
by: Claire Domenger, et al.
Published: (2018-03-01)

Long-term maintenance of dystrophin expression and resistance to injury of skeletal muscle in gene edited DMD mice
by: Dileep R. Karri, et al.
Published: (2022-06-01)

Dual Myostatin and Dystrophin Exon Skipping by Morpholino Nucleic Acid Oligomers Conjugated to a Cell-penetrating Peptide Is a Promising Therapeutic Strategy for the Treatment of Duchenne Muscular Dystrophy
by: Alberto Malerba, et al.
Published: (2012-01-01)

Novel Exon-Skipping Therapeutic Approach for the DMD Gene Based on Asymptomatic Deletions of Exon 49
by: Mario Abaji, et al.
Published: (2022-07-01)

A Genotype-Phenotype Correlation Study of Exon Skip-Equivalent In-Frame Deletions and Exon Skip-Amenable Out-of-Frame Deletions across the <i>DMD</i> Gene to Simulate the Effects of Exon-Skipping Therapies: A Meta-Analysis
by: Saeed Anwar, et al.
Published: (2021-01-01)

Systemic administration of the antisense oligonucleotide NS‐089/NCNP‐02 for skipping of exon 44 in patients with Duchenne muscular dystrophy: Study protocol for a phase I/II clinical trial
by: Takami Ishizuka, et al.
Published: (2023-06-01)

Single Exon Skipping Can Address a Multi-Exon Duplication in the Dystrophin Gene
by: Kane Greer, et al.
Published: (2020-06-01)

Current Outline of Exon Skipping Trials in Duchenne Muscular Dystrophy
by: Gökçe Eser, et al.
Published: (2022-07-01)

Context Dependent Effects of Chimeric Peptide Morpholino Conjugates Contribute to Dystrophin Exon-skipping Efficiency
by: HaiFang Yin, et al.
Published: (2013-01-01)

Upper Limb Changes in DMD Patients Amenable to Skipping Exons 44, 45, 51 and 53: A 24-Month Study
by: Claudia Brogna, et al.
Published: (2023-04-01)

Prime editing optimized RTT permits the correction of the c.8713C>T mutation in DMD gene
by: Cedric Happi Mbakam, et al.
Published: (2022-12-01)

Targeted Exon Skipping to Address “Leaky” Mutations in the Dystrophin Gene
by: Sue Fletcher, et al.
Published: (2012-01-01)

A homology independent sequence replacement strategy in human cells using a CRISPR nuclease
by: Eric Danner, et al.
Published: (2021-01-01)

Pre-clinical dose-escalation studies establish a therapeutic range for U7snRNA-mediated DMD exon 2 skipping
by: Tabatha R. Simmons, et al.
Published: (2021-06-01)

Systemic delivery of an AAV9 exon-skipping vector significantly improves or prevents features of Duchenne muscular dystrophy in the Dup2 mouse
by: Nicolas Wein, et al.
Published: (2022-09-01)

Therapeutic Prospects of Exon Skipping for Epidermolysis Bullosa
by: Franciscus C. Vermeer, et al.
Published: (2021-11-01)

Polypurine Reverse-Hoogsteen Hairpins as a Tool for Exon Skipping at the Genomic Level in Mammalian Cells
by: Véronique Noé, et al.
Published: (2021-04-01)

A <i>Dystrophin</i> Exon-52 Deleted Miniature Pig Model of Duchenne Muscular Dystrophy and Evaluation of Exon Skipping
by: Yusuke Echigoya, et al.
Published: (2021-12-01)

The analysis of DMD gene deletions by multiplex PCR in Indonesian DMD/BMD patients: the era of personalized medicine
by: Kristy Iskandar, et al.
Published: (2019-10-01)

Oligonucleotide Enhancing Compound Increases Tricyclo-DNA Mediated Exon-Skipping Efficacy in the Mdx Mouse Model
by: Flavien Bizot, et al.
Published: (2023-02-01)

The use of genetically humanized animal models for personalized medicine approaches
by: Annemieke Aartsma-Rus, et al.
Published: (2020-02-01)

Pathological alterations in the gastrointestinal tract of a porcine model of DMD
by: Xiaodong Zou, et al.
Published: (2021-07-01)

Histone deacetylase inhibitors improve antisense-mediated exon-skipping efficacy in mdx mice
by: Flavien Bizot, et al.
Published: (2022-12-01)

Investigating the Impact of Delivery Routes for Exon Skipping Therapies in the CNS of DMD Mouse Models
by: Amel Saoudi, et al.
Published: (2023-03-01)

CRISPR-induced exon skipping is dependent on premature termination codon mutations
by: Tingting Sui, et al.
Published: (2018-10-01)